Peregrine Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-625,350
Closed -$6.5M 299
2020
Q1
$6.5M Buy
625,350
+60,631
+11% +$772K 0.23% 138
2019
Q4
$10.1M Sell
564,719
-75,642
-12% -$1.12M 0.26% 142
2019
Q3
$7.99M Buy
640,361
+10,164
+2% +$167K 0.22% 164
2019
Q2
$12.5M Buy
630,197
+159,430
+34% +$3.41M 0.31% 137
2019
Q1
$9.91M Buy
470,767
+36,205
+8% +$661K 0.25% 154
2018
Q4
$8.88M Buy
434,562
+113,063
+35% +$3.54M 0.25% 148
2018
Q3
$11.8M Buy
+321,499
New +$14M 0.28% 146

Other funds holding AXGN

Peregrine Capital Management's AXGN Position: Q2 2020 in Review

Peregrine Capital Management sold out of Axogen (AXGN) in Q2 2020, closing a stake of 625,350 shares — an estimated $6.5M sold.

Peregrine Capital Management first reported a position in AXGN in Q3 2018 and held it in 7 quarters. The position peaked at $12.5M in Q2 2019. 114 funds tracked by Wall St. Rank hold AXGN as of Q2 2020.

  • Peregrine Capital Management reported no remaining Axogen position as of Q2 2020 after selling out during the quarter.
  • Peregrine Capital Management sold 625,350 Axogen shares in Q2 2020, an estimated $6.5M.
  • Peregrine Capital Management first reported a position in Axogen in Q3 2018 and held it in 7 quarters.
  • Peregrine Capital Management's Axogen position peaked at $12.5M in Q2 2019.
  • 114 funds tracked by Wall St. Rank held Axogen as of Q2 2020.

Based on Peregrine Capital Management's 13F filing for Q2 2020, filed 30 Jul 2020.